- Gould et al, "Recent Trends in the Identification of Incidental Pulmonary Nodules," American Journal of Respiratory and Critical Care Medicine, vol. 192, no. 10, 2015.
- Pyenson et al, “No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients.” Journal of Health Economics and Outcomes Research. 2019; 6(3): 118-29.
Managing Incidental Lung Nodules is a Challenge
More than 1.6 million nodules are detected incidentally each year in the US, but only 1 in 3 patients ever receive a clinical follow-up. In addition, it takes on average 8 months for a nodule to be diagnosed as either malignant or benign.1,2
Clinical risk assessment has become a critical component of managing patients with newly discovered lung nodules. Physicians must weigh the benefit of avoiding invasive procedures and the risk of delayed intervention.
Data from the PANOPTIC study in the low to moderate risk population as assessed by the Solitary Pulmonary Nodule (SPN) Calculator3. PANOPTIC was a prospective, observational trial across 33 academic and community sites4.